AstraZeneca

AZ expands role in China, to include robots and health tech
AZ expands role in China, to include robots and health tech
Pharmaforum
AstraZeneca
China
robotics
digital health
artificial intelligence
Flag link:
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
Fierce Pharma
AstraZeneca
COPD
Fasenra
asthma
Flag link:
With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?
With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?
Fierce Pharma
AstraZeneca
GSK
COPD
Trelegy Ellipta
PT010
Flag link:
AstraZeneca grabs an FDA OK for its new leukemia drug, to be marketed as Lumoxiti
AstraZeneca grabs an FDA OK for its new leukemia drug, to be marketed as Lumoxiti
Endpoints
AstraZeneca
hairy cell leukemia
moxetumomab pasudotox
Flag link:
AstraZeneca plc (AZN) Expected to Post Earnings of $0.44 Per Share
AstraZeneca plc (AZN) Expected to Post Earnings of $0.44 Per Share
Daily Political
AstraZeneca
earnings
Flag link:
Another setback for AstraZeneca as lupus drug fails phase 3 test
Another setback for AstraZeneca as lupus drug fails phase 3 test
Fierce Biotech
AstraZeneca
SLE
systemic lupus erythematosus
lupus
anifrolumab
clinical trials
Flag link:
AstraZeneca improves diabetes pen to maintain its market share
AstraZeneca improves diabetes pen to maintain its market share
Pharmaforum
Europe
AstraZeneca
Bydureon BCise
diabetes
injection pen
Flag link:
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
AbbVie
JNJ
FDA
Imbruvica
Rituxan
Roche
AstraZeneca
non-Hodgkin's lymphoma
Waldenström’s macroglobulinemia
Flag link:
Major Expected Events from AstraZeneca’s R&D in H2 2018
Major Expected Events from AstraZeneca’s R&D in H2 2018
Market Realist
AstraZeneca
China
Lynparza
Tagrisso
Imfinzi
Flag link:
AstraZeneca inhaler lags GSK drug in lung disease trial
AstraZeneca inhaler lags GSK drug in lung disease trial
Reuters
AstraZeneca
GSK
clinical trials
Bevespi Aerosphere
inhalers
COPD
Anoro
Flag link:
AstraZeneca gets further approval for Tagrisso in Japan
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
AstraZeneca
Japan
Tagrisso
non-small cell lung cancer
Flag link:
AstraZeneca, its new HQ delayed and way over budget, weighs a construction partner swap: report
AstraZeneca, its new HQ delayed and way over budget, weighs a construction partner swap: report
Fierce Pharma
AstraZeneca
Flag link:
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
Fierce Biotech
Entasis
IPOs
AstraZeneca
clinical trials
beta-lactams
Flag link:
PARP inhibitors show promise for treating ALS and other brain disorders
PARP inhibitors show promise for treating ALS and other brain disorders
Fierce Biotech
PARP inhibitors
AstraZeneca
Lynparza
Tesaro
Zejula
ALS
Flag link:
Drug firms fight US government’s Iraq corruption probe
Drug firms fight US government’s Iraq corruption probe
Pharmaforum
Iraq
DOJ
AstraZeneca
Roche
JNJ
GE
Pfizer
Flag link:
AstraZeneca to Pay $110 Million to Settle Texas Drug Suits
AstraZeneca to Pay $110 Million to Settle Texas Drug Suits
Yahoo/Bloomberg
AstraZeneca
Texas
Medicaid
Flag link:
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Endpoints
AstraZeneca
gout
lesinurad
Ironwood
Flag link:
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
CP Wire
AstraZeneca
Merck
selumetinib
Array Biopharma
orphan drugs
NF1
neurofibromatosis
Flag link:
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
AstraZeneca
Merck
selumetinib
Array Biopharma
Flag link:
Justice Department probes claims that AstraZeneca bribed Iraqi terrorists to win contracts
Justice Department probes claims that AstraZeneca bribed Iraqi terrorists to win contracts
Fierce Pharma
AstraZeneca
DOJ
Iraq
terrorism
Flag link:

Pages